In summary, when mice with invasive candidiasis are treated with Dectin-1 or Dectin-2 targeted DectiSomes delivering 0.2 mg/kg AmB, they both showed significantly improved mouse survival relative to AmB-LL treatment. Here, CLEC7A is linked to Candidiasis, Invasive.